Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Law Offices Files Lawsuit Against Sepracor
Law Offices of Howard G Smith has filed class action lawsuit in the Court of Chancery for the State of Delaware on behalf of all public stockholders who
Law Offices of Howard G Smith has filed class action lawsuit in the Court of Chancery for the State of Delaware on behalf of all public stockholders who
QuatRx Pharmaceuticals (QuatRx) has reported positive efficacy results from the second of two patient cohorts in the second pivotal phase 3 study of Ophena (ospemifene tablets). Ophena is
Halozyme has reported first patient dosing in a phase 1 pharmacokinetic clinical trial using Enhanze Technology (rHuPH20, recombinant human hyaluronidase) in a subcutaneous formulation of a Roche biologic.
United BioSource (UBC) has acquired Cognitive Drug Research (CDR). The CDR System is used in 1000 trials encompassing approximately 50 different disease areas. CDR maintains healthy subject, patient,
Inviragen has received a $600,000 grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to partially support its efforts to
Ascenta Therapeutics has revealed that (following the approval by the FDA for AT-406, an orally-active, small molecule, multi-IAP antagonist) it will initiate a phase 1 clinical trial in
Par Pharmaceutical has received final approval from the FDA for its Abbreviated New Drug Application for nateglinide tablets. Nateglinide is a generic version of Novartis’ Starlix. The company
Acceleron Pharma (Acceleron) has provided preliminary results from the ACE-031 phase 1 single dose clinical trial, demonstrating that ACE-031 increased lean body mass and muscle volume. The results
Teva Pharmaceutical (Teva) has provided data that demonstrated patients treated for 10 and 15 years with Copaxone had significant reduction in disease severity. The long-term analysis utilised the
The American Chemical Society (ACS) via its Green Chemistry Institute and NSF International, a public health and safety organization, are aiming to develop a green chemistry standard, which